2-(cyclohex-2-en-1-yl)-1-[6-(2-hydroxypropan-2-yl)pyridin-2-yl]-6-[(2-methyl-1,2,3,4-tetrahydroisoquinolin-7-yl)amino]-1H,2H,3H-pyrazolo[3,4-d]pyrimidin-3-one

ID: ALA5286243

Max Phase: Preclinical

Molecular Formula: C29H33N7O2

Molecular Weight: 511.63

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CN1CCc2ccc(Nc3ncc4c(=O)n(C5C=CCCC5)n(-c5cccc(C(C)(C)O)n5)c4n3)cc2C1

Standard InChI:  InChI=1S/C29H33N7O2/c1-29(2,38)24-10-7-11-25(32-24)36-26-23(27(37)35(36)22-8-5-4-6-9-22)17-30-28(33-26)31-21-13-12-19-14-15-34(3)18-20(19)16-21/h5,7-8,10-13,16-17,22,38H,4,6,9,14-15,18H2,1-3H3,(H,30,31,33)

Standard InChI Key:  VOWKUHQZSGCZFU-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 38 43  0  0  0  0  0  0  0  0999 V2000
    3.4325    0.9643    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8417    0.2480    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6625    0.2480    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0781    0.9543    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6689    1.6706    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8440    1.6706    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6119    0.9643    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.1271    0.2936    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.3407    0.5479    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6289    0.1393    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0839    0.5467    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0839    1.3721    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.6264    1.7902    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3407    1.3744    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1251    1.6308    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3774    2.4117    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7934    0.1343    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5053    0.5426    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5053    1.3705    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2199    1.7803    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9309    1.3705    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9309    0.5426    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2199    0.1244    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6493    0.1293    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3652    0.5487    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3652    1.3765    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6422    1.7852    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0781    0.1421    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3819   -0.4864    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1895   -0.6543    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.4386   -1.4407    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8858   -2.0529    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0838   -1.8788    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8291   -1.0986    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2407   -1.6148    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7954   -1.0042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4542   -2.4117    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0375   -1.8283    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  1  6  1  0
  1  7  1  0
  7  8  1  0
  8  9  1  0
 10  9  2  0
 11 10  1  0
 12 11  2  0
 12 13  1  0
  9 14  1  0
 14 13  2  0
  7 15  1  0
 15 14  1  0
 15 16  2  0
 17 11  1  0
 18 17  1  0
 19 18  1  0
 20 19  2  0
 21 20  1  0
 21 22  2  0
 18 23  2  0
 22 23  1  0
 22 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 21 27  1  0
 28 25  1  0
 29  8  1  0
 30 29  2  0
 30 31  1  0
 32 31  2  0
 33 32  1  0
 29 34  1  0
 34 33  2  0
 35 31  1  0
 35 36  1  0
 35 37  1  0
 35 38  1  0
M  END

Alternative Forms

  1. Parent:

    ALA5286243

    ---

Associated Targets(Human)

PLK1 Tchem Serine/threonine-protein kinase PLK1 (28605 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
WEE1 Tchem Serine/threonine-protein kinase WEE1 (1772 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A-427 (643 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NCI-H23 (49055 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 511.63Molecular Weight (Monoisotopic): 511.2696AlogP: 4.22#Rotatable Bonds: 5
Polar Surface Area: 101.10Molecular Species: NEUTRALHBA: 9HBD: 2
#RO5 Violations: 1HBA (Lipinski): 9HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
CX Acidic pKa: 12.81CX Basic pKa: 8.21CX LogP: 3.71CX LogD: 2.83
Aromatic Rings: 4Heavy Atoms: 38QED Weighted: 0.39Np Likeness Score: -0.55

References

1. Guler S, DiPoto MC, Crespo A, Caldwell R, Doerfel B, Grossmann N, Ho K, Huck B, Jones CC, Lan R, Musil D, Potnick J, Schilke H, Sherer B, Simon S, Sirrenberg C, Zhang Z, Liu-Bujalski L..  (2023)  Selective Wee1 Inhibitors Led to Antitumor Activity In Vitro and Correlated with Myelosuppression.,  14  (5): [PMID:37197456] [10.1021/acsmedchemlett.2c00481]

Source